Contrast Media Injectors Market To Reach US$ 2.16 Billion By 2027

How Big is the Contrast Media Injectors Market ? :

IMARC Group's latest report, titled "Contrast Media Injectors Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027", the global contrast media injectors market reached a value of US$ 1.46 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 2.16 Billion by 2027, exhibiting a CAGR of 6.30% during 2022-2027.

What is Contrast Media Injectors ? :

Contrast media injectors are medical devices designed to administer contrast media into the bloodstream of patients. They help enhance the visibility of internal organs and tissues during medical imaging procedures, such as computed tomography (CT) scans, magnetic resonance imaging (MRI) scans, and X-rays. They are programmed to deliver precise amounts of contrast media at a specific rate, ensure consistent image quality and reduce the risk of human error. They offer several benefits over manual injection methods, including increased accuracy, consistency, and efficiency. As a result, they are an essential tool for radiologists and other medical professionals in the diagnosis and treatment of various medical conditions.

Request Free Sample Report (Exclusive Offer on this report): https://www.imarcgroup.com/contrast-media-injectors-market/requestsample

Who are the key Players Operating in the Industry ? :

The competitive landscape of the industry has also been examined along with the profiles of the key players being,

• APOLLO RT Co. Ltd
• Bayer AG
• Bracco Imaging S.p.A
• General Electric Company
• Guerbet
• Medtron AG
• Nemoto Kyorindo Co. Ltd
• Shenzhen Anke High-tech Co. Ltd
• Shenzhen Seacrown Electromechanical Co. Ltd
• Sino Medical-Device Technology Co. Ltd
• ulrich GmbH & Co. KG

What are the Growth Prospects and Trends in the Contrast Media Injectors Industry ? :

At present, there is a rise in the prevalence of chronic diseases, such as diabetes, cancer, stroke, and Alzheimer's disease, among the masses across the globe. This, along with the thriving healthcare industry, represents one of the key factors supporting the growth of the market. Besides this, the increasing demand for minimally invasive surgical (MIS) procedures as it causes less pain, scarring, and trauma to the patient as compared to traditional open surgery is strengthening the growth of the market.

Moreover, key market players are focusing on their end-to-end supply chains to reduce product prices and enhance the quality and services associated with contrast media injectors.

Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/contrast-media-injectors-market

Key Market Segmentation:

Breakup by Product Type:

• Consumables
• Syringes
• Tubes
• Others
• Injector Systems
• CT Injectors
• MRI Injectors
• Angiography Injectors
• Accessories

Breakup by Injectors Type:

• Single-head Injectors
• Dual-head Injectors
• Syringeless Injectors

Breakup by Application:

• Radiology
• Interventional Cardiology
• Interventional Radiology

Breakup by End User:

• Hospitals
• Ambulatory Surgery Centers
• Diagnostics Imaging Centers

Breakup by Region:

• North America (United States, Canada)
• Europe (Germany, France, United Kingdom, Italy, Spain, Others)
• Asia Pacific (China, Japan, India, Australia, Indonesia, Korea, Others)
• Latin America (Brazil, Mexico, Others)
• Middle East and Africa (United Arab Emirates, Saudi Arabia, Qatar, Iraq, Other)

Key Highlights of the Report:

• Market Performance (2016-2021)
• Market Outlook (2022-2027)
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

Related Report By IMARC Group:

• https://www.imarcgroup.com/non-pvc-iv-bags-market

• https://www.imarcgroup.com/office-supplies-market

• https://www.imarcgroup.com/preimplantation-genetic-testing-market

• https://www.imarcgroup.com/premium-denim-jeans-market

• https://www.imarcgroup.com/companion-animal-health-market

• https://www.imarcgroup.com/high-temperature-insulation-materials-market

• https://www.imarcgroup.com/small-cell-power-amplifier-market

• https://www.imarcgroup.com/united-states-online-video-platform-market

Contact us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.